{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-052405","form_type":"8-K","ticker":"ONMD","cik":"0001849380","company_name":"OneMedNet Corp","filed_at":"2024-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.040402+00:00","generated_at":"2026-05-28T22:51:10.126269+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"OneMedNet regains Nasdaq compliance after filing overdue quarterly reports","bullets":["Received Nasdaq notice confirming compliance with Listing Rule 5250(c)(1) after filing Q1-Q3 2024 Form 10-Qs.","Appointed Bob Golden as interim CFO, hired Director of Business Development and VP of Marketing.","Signed agreement with Bayer's AI Innovation Platform in early December.","Raised ~$6.4M in private placements with Off the Chain Capital and Discovery Capital Management affiliate.","Adopted Bitcoin on balance sheet treasury strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-052405","json":"https://secwatch.observer/filing/0001493152-24-052405.json","markdown":"https://secwatch.observer/filing/0001493152-24-052405.md","text":"https://secwatch.observer/filing/0001493152-24-052405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1849380/000149315224052405/0001493152-24-052405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1849380/000149315224052405/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:51:10.126269+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}